Clinical Trial Update: Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma [NA]

View source ↗

Summary

Clinical trial update evaluating an ex vivo drug combination optimization platform for recurrent high-grade astrocytic glioma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioma

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Glioma, Astrocytic | NA | Status: RECRUITING